| Bayer (Schweiz) AG - Vitrakvi 20 mg/ml, Lösung zum Einnehmen | | 67282 | | 01 | | Vitrakvi 20 mg/ml | | Lösung zum Einnehmen | | L01EX12 | | Larotrectinib | | 28.05.2020 | | |
| | Composition | | larotrectinibum 20 mg ut larotrectinibi sulfas, acidum citricum, maltodextrinum, triethylis citras, aromatica (Erdbeer) cum alcohol benzylicus, propylenglycolum, hydroxypropylbetadexum 174.6 mg, E 211 2 mg, natrii citras dihydricus, sucralosum, aqua purificata, ad solutionem pro 1 ml corresp. natrium max. 4.17 mg. | | Packungsbestandteile | | Solution (orale) | | | | | | | | Principe actif | Concentr. |
|---|
| Larotrectinibum | 20 mg/ml |
| | BAG: Principe actif | Concentr. |
|---|
| Larotrectinibum | 20 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Acide Citrique | | | | Aqua Purificata | | | | Aromatica (Erdbeer) cum Alcohol Benzylicus | | | | E 211 | 2 mg/ml | conserv. | | Hydroxypropylbetadexum | 174.6 mg/ml | | | Maltodextrine | | | | Natrii Citras Dihydricus | | | | Propylenglycol | | | | Sucralosum | | | | Triethylis Citras | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 002 | 100 ml | 1932.71 | 2118.35 | A | LS | Non |
|
|
